Abstract:
본 발명은 유효성분으로 다시마추출물, 미역추출물 및 차전자추출물을 함유하는 화장료 조성물에 관한 것이다. 보다 상세하게는, 본 발명은 유효성분으로 다시마추출물, 미역추출물 및 차전자추출물을 함유하여 피부의 보습력을 향상시키고 이와 더불어 피부 탄력도 증진시키는 화장료 조성물에 관한 것이다.
Abstract:
본 발명은 포공영, 승마, 산약 및 고본 추출물 중 1종 이상의 한약재 추출물을 유효성분으로 함유함으로써 염증 관련 인자들을 억제시키는 항염증 효능을 가지고, 상처 조직의 재상피화를 촉진시켜 염증기에서 증식기로의 진행을 빠르게 도와주는 상처치료 효능을 가지며, 해독 작용에 관여하는 효소들의 유전자 발현을 증가시켜 UV 등 외부 자극에 의한 피부 손상을 억제하여 피부 노화를 억제하는 항노화 효능을 가지는 피부 외용제 조성물에 관한 것이다. 포공영, 승마, 산약, 고본, 한방, 한약, 상처 치유, 항염증, 해독, 피부 노화, 피부손상, 피부 외용제
Abstract:
PURPOSE: A cosmetic composition for stabilized higher oily part is provided to ensure emollient effect and water resistance. CONSTITUTION: A cosmetic composition stabilized higher oily part is a water/oil/water emulsified composition in which 3-56 weight% of oil ingredient is stabilized. The water/oil formulation contains: 1-8 weight% of silicon emulsifying agent and PEG-added dipolyhydroxyalkylate emulsifying agent; 2.5-8 weight% of hectorite oil dextrin and dextrin alkaylate oil tackifier; 0.1-5 weight% of salt, and 20-45 weight% of polar oil. The salt is sodium chloride and magnesium sulfate.
Abstract:
PURPOSE: A cosmetic composition for massage is provided to control absorption rate and to ensure soft massage effect. CONSTITUTION: A cosmetic composition for massage contains 1-5 weight% of saccharide surfactant, 5-25 weight% of oil, 0.1-3 weight% of gums. The oil contains polar oil and non-polar oil in a ratio of 1-3:1. The saccharide surfactant is prepared by ester bond of alkyl fatty acid with ribose, xylose, arabinose, glucose, mannose, galactose, xylose, or fructose. The polar oil contains a functional group of carboxylic acid(COO-), ketone(CO-), or hydroxyl group(OH). The gums are xanthan gum, carrageenans gum, guar gum, gellan gum, or locust bean gum.
Abstract:
PURPOSE: A cosmetic composition is provided to improve UV protection by uniform application on the skin. CONSTITUTION: A cosmetic composition for UV protection has silicon film forming agent containing MQ resin. The silicon film forming agent is selected from the group consisting of trimethylsiloxysilicate/cyclotetrasiloxane, trimethylsiloxysilicate/cyclopentasiloxane, and trimethysiloxysiliate/dimethicone. The silicon film forming agent is contains 5.0-30.0 weight% based on total weight.
Abstract:
PURPOSE: A pharmaceutical composition containing 2-cyclopentene-1-one oxime derivative is provided to promote adipose lysis in adipocytes(3T3-L1) and to prevent and treat lipid metabolic diseases including obesity and diabetes. CONSTITUTION: A pharmaceutical composition for preventing and treating lipid metabolic diseases contains 2-cyclopenten-1-one oxime derivative compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. In chemical formula 1, R1 is linear or branched C1-C10 alkyl group or C3-C7 cycloalkyl group, or phenyl group with or without substituent. The phenyl group is denoted by chemical formula 2. The pharmaceutical composition is used for preventing and treating obesity, diabetes, or dyslipidemia.
Abstract:
PURPOSE: An oriental heating patch using a Korean paper is provided to control the temperature of a heating layer, and to maintain the activity of effective components laminated on the patch for a long time. CONSTITUTION: An oriental heating patch comprises the following: a nonwoven fabric layer adhered with permeable polyethylene and a Korean paper; a herbal component layer coated with a film composition formed by a herb medicine extract, saccharide, polyol, and oil; a heating film layer including a heating composition containing iron powder, activated charcoal, paper mulberry fiber, cellulose gum, and sodium polyacrylate; and a warm non-woven fabric. The herbal component layer contains 0.1~40wt% of herb medicine extract, 1~40wt% of saccharide, 1~20wt% of polyol, and 1~30wt% of oil.
Abstract:
PURPOSE: A novel compound which functions as a vanilloid receptor 1(VR1) antagonist is provided to prevent or treat disease related to hair growth, rhinitis, and pancreatitis. CONSTITUTION: A vanilloid receptor antagonist compound is denoted by chemical formula I. A pharmaceutical composition contains the compound, isomer, or pharmaceutically acceptable salt thereof. The composition is used for preventing or treating arthritis disease, neuropathy, HIV related neuropathy, nerve injury, neurodegeneration, cerebral apoplexy, urinary incontinence, cough, neuropathy/allergy/inflammation skin disease, atopic dermatitis, psoriasis, pruritus, the prurigo, acouesthesia, aliasing, bregma anaphylaxis, effluvium, or alopecia.
Abstract:
PURPOSE: A cosmetic composition relieving swelling on the face is provided to form natural moisture membrane, ensure elasticity on the skin, and to enhance density of dermis. CONSTITUTION: A cosmetic composition relieving swelling on the face contains 0.3-50 weight% of starch, 0.1-50 weight% of gum, and 0.3-5- weight% of silica. The composition further contains 0.05-50 weight% of walnut extract or Morus alba L. extract. The starch is corn starch, sweet potato starch, potato starch, wheat starch. The gum is xanthan gum, carrageenan gum, guar gum, gellan gum, or locust bean gum.
Abstract:
A cosmetic composition for skin whitening, which contains Oldenfandia diffusa Roxburgh extract and Rheum undulatum extract is provided to suppress the formation of melanocyte and prevent pigmentation. A cosmetic composition for skin whitening comprises 0.001~10 weight% of Oldenfandia diffusa Roxburgh extract and 0.001~5.0 weight% of Rheum undulatum as active ingredients. A method for obtaining the Oldenfandia diffusa Roxburgh extract comprises a step of adding 60-80‹C of purified water to wash for 10-20 minutes; a step of adding 80~85‹C of purified water to extract the Oldenfandia diffusa Roxburgh; and a step of cooling the extract to 20-30‹C, filtering and removing solid portion. The cosmetic composition is used in the form of skin softener, emulsion, massage cream, nutrition cream, pack, patch, gel, stick, and spray.